Anest. intenziv. Med. 2010;21(1):3-5

Po stopách ztracené rezistenceEditorial

Karel Škarvan

Published: February 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Škarvan K. Po stopách ztracené rezistence. Anest. intenziv. Med. 2010;21(1):3-5.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Patel, M. R., Mahaffey, K. W., Armstrong P. W. et al. Baseline white cell count and interleukin-6 levels provide complementary prognostic information in acute myocardial infarction: Results from the CARDINAL Trial. J. Am. Coll. Cardiol., 2004, 43, Supp 291 A. Go to original source...
    2. Valencia, R., Theroux, P., Granger, C. B. et al. Congestive heart failure and cardiogenic shock complicating acute myocardial infarction have high mortality and are associated with intense inflammatory response: Results from the CARDINAL Trials. J. Am. Coll. Cardiol., 2004, 43, Supp. 291 A. Go to original source...
    3. Geppert, A., Dorninger, G. A., Delle-Karth, G. et al. Plasma concentrations of interleukin-6, organ failure, vasopressor support, and successful coronary revascularization in predicting 30-day mortality of patients with cardiogenic shock complicationg myocardial infarction. Crit. Care Med., 2006, 34, p. 2234-2235. Go to original source... Go to PubMed...
    4. Kohsaka, S., Menon, V., Lowe, A. M. et al. Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock. Arch. Intern. Med., 2005, 165, p. 1643-1650. Go to original source... Go to PubMed...
    5. Jeger, R. V., Assmann, S. F., Yehudai, L. et al. Causes of death and re-hospitalization in cardiogenic shock. Acute Cardiac Care, 2007, 9, p. 25-33. Go to original source... Go to PubMed...
    6. Thomas, M., Malmcrona, R., Shillingford, J. Circulatory changes associated with systemic hypotension in patients with acute myocardial infarction. Brit. Heart, 1966, 28, p. 108-117. Go to original source... Go to PubMed...
    7. Kuhn, L. A. The treatment of cardiogenic shock. Part I. The nature of cardiogenic shock Am. Heart J., 1967, 74, p. 578-581. Go to original source... Go to PubMed...
    8. Lim, N., Dubois, M. J., de Backer, D., Vincent J. L. Do all survivors of cardiogenic shock die with a low cardiac index? Chest, 2003, 124, p. 1885-1891. Go to original source... Go to PubMed...
    9. Hochman, J. S. Cardiogenic shock complicating acute myocardial infarction. Extending the paradigm. Circulation, 2003, 107, p. 2989-3002. Go to original source... Go to PubMed...
    10. Kohsaka, S., Menon, V., Iwata, K. et al. Microbiological profile of septic complication in patients with cardiogenic shock following acute myocardial infarction (from the SHOCK Study). Am. J. Cardiol., 2007, 99, p. 802-804. Go to original source... Go to PubMed...
    11. Berk, J. L., Hagen, J. F., Maly, G., Koo, R. The treatment of shock with beta adrenergic blockade. Arch. Surg., 1972, 104, p. 46-51. Go to original source... Go to PubMed...

    Return to the content


    Anesteziologie a intenzivní medicína

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.